Immunomedics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -4.08%75.260.0%$2386.10m
NVAXNovavax, Inc. 9.44%172.0099.2%$1277.08m
GILDGilead Sciences, Inc. -2.33%69.231.0%$527.52m
AMGNAmgen, Inc. -0.98%241.221.3%$510.60m
REGNRegeneron Pharmaceuticals, Inc. -2.14%634.582.5%$465.43m
SRNESorrento Therapeutics, Inc. 4.91%13.471.8%$437.71m
BNTXBioNTech SE -2.55%81.050.0%$402.35m
VRTXVertex Pharmaceuticals, Inc. -1.46%271.681.9%$378.96m
VXRTVaxart, Inc. 10.29%9.810.0%$330.19m
ILMNIllumina, Inc. 2.24%402.483.5%$327.09m
BIIBBiogen, Inc. -0.06%275.911.6%$326.72m
IBIOiBio, Inc. 1.33%4.451.8%$185.13m
EBSEmergent BioSolutions, Inc. 8.44%132.986.4%$175.48m
SGENSeattle Genetics, Inc. -1.16%163.156.1%$173.07m
ALXNAlexion Pharmaceuticals, Inc. -2.34%102.762.0%$170.87m

Company Profile

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.